The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jul. 22, 2025
Filed:
Jun. 08, 2022
Applicant:
Caris Mpi, Inc., Irving, TX (US);
Inventors:
Daniel D. Von Hoff, Scottsdale, AZ (US);
David M. Loesch, Greenwood, IN (US);
Arlet Alarcon, Phoenix, AZ (US);
Robert J. Penny, Lebanon, IN (US);
Alan Wright, Irving, TX (US);
Matthew J. McGinniss, San Diego, CA (US);
Ryan P. Bender, Phoenix, AZ (US);
Traci Pawlowski, Laguna Hills, CA (US);
Assignee:
Caris MPI, Inc., Irving, TX (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
G01N 35/00 (2006.01); B01L 7/00 (2006.01); C12Q 1/6841 (2018.01); C12Q 1/6874 (2018.01); C12Q 1/6886 (2018.01); C40B 60/12 (2006.01); G01N 33/543 (2006.01); G01N 33/574 (2006.01); G16B 20/00 (2019.01); G16B 20/10 (2019.01); G16B 20/20 (2019.01); G16B 20/40 (2019.01); G16B 25/00 (2019.01); G16B 25/10 (2019.01); G16B 30/00 (2019.01); G16B 30/10 (2019.01); G16B 35/00 (2019.01); G16B 40/00 (2019.01); G16B 40/10 (2019.01); G16B 45/00 (2019.01); G16B 50/00 (2019.01); G16B 50/30 (2019.01); G16B 99/00 (2019.01); G16C 20/60 (2019.01); G16H 10/20 (2018.01); G16H 15/00 (2018.01); G16H 20/10 (2018.01); G16H 40/63 (2018.01); G16H 50/20 (2018.01); G16H 70/40 (2018.01);
U.S. Cl.
CPC ...
G01N 35/00029 (2013.01); B01L 7/52 (2013.01); C12Q 1/6841 (2013.01); C12Q 1/6874 (2013.01); C12Q 1/6886 (2013.01); C40B 60/12 (2013.01); G01N 33/54366 (2013.01); G01N 33/574 (2013.01); G01N 33/57407 (2013.01); G01N 33/57415 (2013.01); G01N 33/57419 (2013.01); G01N 33/57423 (2013.01); G01N 33/5743 (2013.01); G01N 33/57434 (2013.01); G01N 33/57438 (2013.01); G01N 33/57442 (2013.01); G01N 33/57449 (2013.01); G01N 33/57484 (2013.01); G01N 35/00871 (2013.01); G16B 20/00 (2019.02); G16B 20/10 (2019.02); G16B 20/20 (2019.02); G16B 20/40 (2019.02); G16B 25/00 (2019.02); G16B 25/10 (2019.02); G16B 30/00 (2019.02); G16B 30/10 (2019.02); G16B 35/00 (2019.02); G16B 40/00 (2019.02); G16B 40/10 (2019.02); G16B 45/00 (2019.02); G16B 50/00 (2019.02); G16B 50/30 (2019.02); G16B 99/00 (2019.02); G16C 20/60 (2019.02); G16H 10/20 (2018.01); G16H 15/00 (2018.01); G16H 20/10 (2018.01); G16H 40/63 (2018.01); G16H 50/20 (2018.01); G16H 70/40 (2018.01); C12Q 2600/106 (2013.01); C12Q 2600/112 (2013.01); C12Q 2600/156 (2013.01); C12Q 2600/158 (2013.01); C12Q 2600/16 (2013.01); G01N 2035/00138 (2013.01); G01N 2035/00158 (2013.01); G01N 2035/00326 (2013.01); G01N 2035/00346 (2013.01); G01N 2035/00366 (2013.01); G01N 2035/00881 (2013.01); G01N 2035/0091 (2013.01); G01N 2333/47 (2013.01); G01N 2333/9029 (2013.01); G01N 2333/91205 (2013.01); G01N 2333/99 (2013.01); G01N 2500/04 (2013.01); G01N 2800/52 (2013.01); Y02A 90/10 (2018.01);
Abstract
Provided herein are methods and systems of molecular profiling of diseases, such as cancer. In some embodiments, the molecular profiling can be used to identify treatments for a disease, such as treatments that were not initially identified as a treatment for the disease or not expected to be a treatment for a particular disease.